Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine
Phase of Trial: Phase IV
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Atorvastatin (Primary) ; Hepatitis B vaccine recombinant
- Indications Hepatitis B
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 21 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials record.
- 01 Aug 2012 New source identified and integrated (Iranian Registry of Clinical Trials; IRCT201109147556N1).